CureVac N.V.
NasdaqGM:CVAC
$ 9.00
$-3.62 (-28.68%)
$ 9.00
$-3.62 (-28.68%)
End-of-day quote: 09/20/2022

CVAC - CureVac N.V. Stock Prediction 2025 - 2030

For CureVac N.V. the 5 year risk analysis shows 0 out of 0 areas green. In the TopGraphs chart you can see if NasdaqGM:CVAC is undervalued. If the price is below the blue line, this is a buy signal for the CVAC stock.

$9.06
Forecast 2022
$11.33
Forecast 2025
$16.46
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2022
$9.06
Forecast 2025
$11.33
Forecast 2030
$16.46
TopGraphs Quality Ranking
Underperform

CureVac N.V. Stock Forecast 2022

$12.24

In the last five quarters, CureVac N.V.’s Price Target has risen from $0.00 to $9.00 - a 100% increase. One analysts predict that CureVac N.V.’s share price will increase in the coming year, reaching $12.24. This would represent an increase of 36%.

36%
36

Highest Price Target $32.68

Average Price Target $12.24

Lowest Price Target $8.78

CureVac N.V. Stock Forecast 2025

Stock Prediction for the Price of One CureVac N.V. Share in Jan 2025.

In Jan 2025 analysts predict a share price of $10.58. An increase of 17.61% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Feb 2025.

In Feb 2025 analysts predict a share price of $10.65. An increase of 18.36% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Mar 2025.

In Mar 2025 analysts predict a share price of $10.72. An increase of 19.12% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Apr 2025.

In Apr 2025 analysts predict a share price of $10.79. An increase of 19.87% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in May 2025.

In May 2025 analysts predict a share price of $10.86. An increase of 20.63% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Jun 2025.

In Jun 2025 analysts predict a share price of $10.92. An increase of 21.38% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Jul 2025.

In Jul 2025 analysts predict a share price of $10.99. An increase of 22.14% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Aug 2025.

In Aug 2025 analysts predict a share price of $11.06. An increase of 22.89% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Sep 2025.

In Sep 2025 analysts predict a share price of $11.13. An increase of 23.65% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Oct 2025.

In Oct 2025 analysts predict a share price of $11.20. An increase of 24.4% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Nov 2025.

In Nov 2025 analysts predict a share price of $11.26. An increase of 25.16% compared to today's share price.

Stock Prediction for the Price of One CureVac N.V. Share in Dec 2025.

In Dec 2025 analysts predict a share price of $11.33. An increase of 25.91% compared to today's share price.

CureVac N.V. Stock Predictions 2030

CureVac N.V. Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $15.37. An increase of 70.82% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $15.47. An increase of 71.91% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $15.57. An increase of 73.01% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $15.67. An increase of 74.1% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $15.77. An increase of 75.2% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $15.87. An increase of 76.3% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $15.97. An increase of 77.39% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $16.06. An increase of 78.49% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $16.16. An increase of 79.59% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $16.26. An increase of 80.68% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $16.36. An increase of 81.78% compared to the previous month's estimate.

CureVac N.V. Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $16.46. An increase of 82.87% compared to the previous month's estimate.

Company Info

P/E Ratio
0.0
Beta
0.00
Price-to-book Ratio
2.42
Market Cap
1.69B
TEV
N/A
LT Debt/Cap
N/A
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$0.00
Country
Website

About CureVac N.V.

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

CureVac N.V. Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
0.0
Beta
0.00
Price-to-book Ratio
2.42
Market Cap
1.69B
TEV
N/A
LT Debt/Cap
N/A
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$0.00
Country
Website

Financials

Year Year 2020
Rev. Revenue
48.87
GM % Gross Margin %
71.1
OI Operating Income
-133.55
OM Operating Margin
-273.27
NI Net Income
-129.12
EPS % Earnings Per Share %
-1.93 -0.98
Div. Dividends
0.00
PR % Payout Ratio %
0
Sha. Shares
180
OCF Operating Cash Flow
522
CS Cap Spending
-36
FCF Free Cash Flow
486
FCFS Free Cash Flow Per Share
3.59

CureVac N.V. Analyst Ratings Frequently Asked Questions

Who are the analysts watching CureVac N.V.?

The following analysts have recently covered CureVac N.V.:

Berenberg
BofA Global Research
Deutsche Bank
Guggenheim Securities, LLC
Jefferies LLC
JMP Securities
Marktfeld
Morningstar Inc.
(This information refers to the last 90 days.)

Who are the sell-side analysts watching CureVac N.V.?

The following sell-side analysts have recently covered CureVac N.V.:

Shu, Zhiqiang
Meacham, Geoffrey Christopher
Papadakis, Emmanuel Douglas
Fernandez, Seamus Christopher
Yang, Eun Kyung
Buchanan, Douglas Royal
Paraskevopoulos, Michail
Elfman, Rachel
(This information refers to the last 90 days.)

© Copyright 2022 | TopGraphs™ | All Rights Reserved

To use TopGraphs™, you must accept our Terms and Conditions and Privacy Policy